SCHEMBL7960772

SCHEMBL7960772

Oc1c(Br)cc(Nc2nc(Nc3cc(Br)c(O)c(Br)c3)nc(Nc3cc(Br)c(O)c(Br)c3)n2)cc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ JAK3 P52333 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ GFER P55789 1/20 0.37
▸ TTR P02766 2/20 0.37
▸ RECQL P46063 2/20 0.37
▸ ALB P02768 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10554859 0.83 CYP3A4 (0.55) CYP3A4TSHRTDP1JAK3MKNK1
SCHEMBL2087642 0.73 BACE1 (0.42) MEN1KMT2AMAPTMAPK1RECQL
SCHEMBL7961759 0.73 TTR (0.44) CYP3A4TSHRMEN1KMT2AMAPT
SCHEMBL8439142 0.69 TSHR (0.50) CYP3A4TSHRTDP1JAK3MKNK1
SCHEMBL11632846 0.67 NQO2 (0.38) CYP3A4TSHRTDP1MEN1KMT2A
Hydrochloric Acid SCHEMBL11750655 0.65 NQO2 (0.36) CYP3A4TSHRTDP1MEN1KMT2A
SCHEMBL23643511 0.64 NFKB1 (0.52) CYP3A4TSHRMEN1KMT2AMAPT
SCHEMBL13759771 0.64 ARG1 (0.44) MEN1KMT2AMAPTMAPK1CA1
SCHEMBL12895790 0.64 MAPT (0.41) MEN1KMT2AMAPTALDH1A1MAPK1
SCHEMBL25495161 0.64 MAPT (0.49) MEN1KMT2AMAPTALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6262053-B1 EFFECTIVE FOR TREATING TUMOR CELLS AND PARTICULARLY EFFECTIVE TO INDUCE APOPTOSIS IN LEUKEMIA AND BREAST TUMOR CELLS. PARKER HUGHES INSTITUTE 2001-07-17 — — US claimed
Send feedback